This MHRA-certified cutting-edge unit specialises in the production of Sterile Investigational Medicinal Products MIA (IMP), meeting the highest standards of quality and regulatory compliance. This Facility excels in aseptic sterile fills including sterilising filtration, tailored for clinical trials.Formerly set and licensed in 2020, the sterile facility underwent a transformative relocation to a state-of-the-art facility three times the size of its previous site. This strategic move is driven by an ambitious objective to significantly increase production capacity and capabilities.This transition presents an exceptional opportunity for potential collaborations and partnerships, as we actively seek applications for customized process requirements. With expanded capacity and cutting-edge infrastructure, the facility is well-prepared to incorporate new processes into its production calendar.This expansion demonstrates our dedication to advancing pharmaceutical manufacturing and offering innovative solutions to address the evolving needs of the industry. This article was published on 2022-09-29
